301331.SZ
恩威医药
SZSE · C 制造业 · CN
CNY 21.84
−1.31%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
CNY 2.25B
MomentumView details →
1D Return
−1.31%
YTD Return
−18.91%
RSI (14)
46.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
CNY 2.25B
RSI (14)
46.1
MomentumView details →
1D Return
−1.31%
YTD Return
−18.91%
Similar companies
Latest newsMore news →
Enwei Pharmaceutical's controlling shareholder Enwei Group and shareholder Chengdu Ruijin pledged 840,000 and 1.988 million shares respectively on August 25, 2026, for their own production and operation, with pledge expiry upon application for release.9d agoEnwei Medical's controlling shareholder Enwei Group had 137,584 shares unfrozen by judicial order on July 16, 2026.50d ago